Coeptis Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Coeptis Therapeutics, Inc. reported Increase (Decrease) in Accrued Liabilities of $161.05 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-11-08
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $54.52K.
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $41.11K.
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $65.41K, a 79.97% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was $154.31K, a 75.08% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$424.02K, a 157.91% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $732.15K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 7 month | Increase (Decrease) in Accrued Liabilities 8 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 10 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $54.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $95.64K derived: sum of 2 quarters · filed 2022-11-08 | $161.05K 10-Q · filed 2022-11-08 | $315.37K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-06-30 | $41.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $106.53K 10-Q · filed 2022-08-02 | $260.84K derived: sum of 3 quarters · filed 2022-08-02 | $208.28K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-03-31 | $65.41K 10-Q · filed 2022-05-12 | $219.73K derived: sum of 2 quarters · filed 2022-05-12 | $167.17K derived: sum of 3 quarters · filed 2022-11-08 | -$685.12K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-12-31 | $154.31K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $101.76K derived: sum of 2 quarters · filed 2022-11-08 | -$750.54K derived: sum of 3 quarters · filed 2022-11-08 | -$424.02K 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | -$52.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$904.85K derived: sum of 2 quarters · filed 2022-11-08 | -$578.34K 10-Q · filed 2022-11-08 | $41.01K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$852.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$525.78K 10-Q · filed 2022-08-02 | $93.56K derived: sum of 3 quarters · filed 2022-08-02 | |||||
| 2021-03-31 | $326.52K 10-Q · filed 2022-05-12 | $945.86K derived: sum of 2 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $619.34K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $5.31K 10-KT · filed 2021-05-11 | $732.15K 10-K · filed 2022-03-11 | |||||
| 2020-11-30 | $1.87K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-01-11 | $4.58K 10-Q · filed 2021-01-11 | ||||||
| 2020-09-30 | $35.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $112.81K derived: sum of 2 quarters · filed 2021-11-15 | $112.81K 10-Q · filed 2021-11-15 | |||||
| 2020-08-31 | $2.71K 10-Q/A · filed 2020-11-23 | |||||||
| 2020-06-30 | $77.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $77.00K 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | $0.00 10-Q/A · filed 2021-05-18 | |||||||
| 2019-12-31 | $150.00 10-KT · filed 2021-05-11 | |||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 | |||||||
| 2019-08-31 | $0.00 10-Q/A · filed 2020-11-23 |